1-216418661-T-C

Variant names:

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_206933.4(USH2A):c.504A>G(p.Thr168Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.648 in 1,612,398 control chromosomes in the GnomAD database, including 341,363 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.62 ( 29448 hom., cov: 31)

Exomes 𝑓: 0.65 ( 311915 hom. )

Consequence

USH2A
NM_206933.4 synonymous

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.565

Publications

41 publications found

Variant links:

Genes affected

USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

USH2A Gene-Disease associations (from GenCC):

Usher syndrome type 2
Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
Usher syndrome type 2A
Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
retinitis pigmentosa 39
Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
retinitis pigmentosa
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

USH2A links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.9).

BP6

Variant 1-216418661-T-C is Benign according to our data. Variant chr1-216418661-T-C is described in CliVar as Benign. Clinvar id is 48528.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-216418661-T-C is described in CliVar as Benign. Clinvar id is 48528.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-216418661-T-C is described in CliVar as Benign. Clinvar id is 48528.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-216418661-T-C is described in CliVar as Benign. Clinvar id is 48528.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-216418661-T-C is described in CliVar as Benign. Clinvar id is 48528.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=-0.565 with no splicing effect.

BA1

GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.812 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
USH2A	NM_206933.4 link	c.504A>G	p.Thr168Thr	synonymous_variant	Exon 3 of 72	ENST00000307340.8	NP_996816.3	O75445-1
USH2A	NM_007123.6 link	c.504A>G	p.Thr168Thr	synonymous_variant	Exon 3 of 21		NP_009054.6	O75445-2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	UniProt
USH2A	ENST00000307340.8 link	c.504A>G	p.Thr168Thr	synonymous_variant	Exon 3 of 72	1	NM_206933.4	ENSP00000305941.3	O75445-1
USH2A	ENST00000366942.3 link	c.504A>G	p.Thr168Thr	synonymous_variant	Exon 3 of 21	1		ENSP00000355909.3	O75445-2
USH2A	ENST00000674083.1 link	c.504A>G	p.Thr168Thr	synonymous_variant	Exon 3 of 73			ENSP00000501296.1	O75445-3

Frequencies

GnomAD3 genomes

AF:

0.617

AC:

93643

AN:

151692

Hom.:

29431

Cov.:

show subpopulations

Gnomad AFR

AF:

0.501

Gnomad AMI

AF:

0.733

Gnomad AMR

AF:

0.657

Gnomad ASJ

AF:

0.573

Gnomad EAS

AF:

0.833

Gnomad SAS

AF:

0.623

Gnomad FIN

AF:

0.702

Gnomad MID

AF:

0.468

Gnomad NFE

AF:

0.651

Gnomad OTH

AF:

0.610

GnomAD2 exomes

AF:

0.653

AC:

163677

AN:

250764

AF XY:

0.648

show subpopulations

Gnomad AFR exome

AF:

0.493

Gnomad AMR exome

AF:

0.694

Gnomad ASJ exome

AF:

0.569

Gnomad EAS exome

AF:

0.839

Gnomad FIN exome

AF:

0.694

Gnomad NFE exome

AF:

0.647

Gnomad OTH exome

AF:

0.630

GnomAD4 exome

AF:

0.651

AC:

951291

AN:

1460588

Hom.:

311915

Cov.:

AF XY:

0.648

AC XY:

471157

AN XY:

726636

show subpopulations

African (AFR)

AF:

0.492

AC:

16440

AN:

33394

American (AMR)

AF:

0.692

AC:

30921

AN:

44652

Ashkenazi Jewish (ASJ)

AF:

0.569

AC:

14831

AN:

26084

East Asian (EAS)

AF:

0.851

AC:

33714

AN:

39626

South Asian (SAS)

AF:

0.602

AC:

51933

AN:

86232

European-Finnish (FIN)

AF:

0.693

AC:

36984

AN:

53348

Middle Eastern (MID)

AF:

0.515

AC:

2967

AN:

5758

European-Non Finnish (NFE)

AF:

0.653

AC:

725249

AN:

1111182

Other (OTH)

AF:

0.634

AC:

38252

AN:

60312

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.468

Heterozygous variant carriers

17883

35766

53649

71532

89415

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Exome Hom

Variant carriers

19010

38020

57030

76040

95050

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.617

AC:

93701

AN:

151810

Hom.:

29448

Cov.:

AF XY:

0.621

AC XY:

46074

AN XY:

74156

show subpopulations

African (AFR)

AF:

0.501

AC:

20746

AN:

41402

American (AMR)

AF:

0.657

AC:

10001

AN:

15222

Ashkenazi Jewish (ASJ)

AF:

0.573

AC:

1988

AN:

3468

East Asian (EAS)

AF:

0.833

AC:

4253

AN:

5106

South Asian (SAS)

AF:

0.624

AC:

3013

AN:

4828

European-Finnish (FIN)

AF:

0.702

AC:

7416

AN:

10562

Middle Eastern (MID)

AF:

0.469

AC:

138

AN:

294

European-Non Finnish (NFE)

AF:

0.651

AC:

44193

AN:

67914

Other (OTH)

AF:

0.611

AC:

1286

AN:

2104

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.501

Heterozygous variant carriers

1799

3599

5398

7198

8997

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Genome Hom

Variant carriers

776

1552

2328

3104

3880

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.629

Hom.:

28842

Bravo

AF:

0.610

Asia WGS

AF:

0.691

AC:

2402

AN:

3478

ClinVar

Significance: Benign

Submissions summary: Benign:14

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not specified

Benign:6

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Apr 10, 2023

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Jan 08, 2013

GeneDx

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

PreventionGenetics, part of Exact Sciences

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Feb 19, 2008

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

not provided

Benign:3

Feb 03, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Breakthrough Genomics, Breakthrough Genomics

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:not provided

- -

Nov 29, 2023

ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Usher syndrome type 2A

Benign:3

Sep 16, 2020

Natera, Inc.

Significance:Benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

- -

Jan 12, 2018

Illumina Laboratory Services, Illumina

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 01, 2021

Genome-Nilou Lab

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Retinal dystrophy

Benign:1

Oct 01, 2023

Dept Of Ophthalmology, Nagoya University

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:research

- -

Retinitis pigmentosa

Benign:1

Jan 12, 2018

Illumina Laboratory Services, Illumina

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.90

CADD

Benign

0.71

(source)

DANN

Benign

0.41

PhyloP100

-0.56

Mutation Taster

=100/0

polymorphism (auto)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over